Literature DB >> 16422829

The impact of intralesional interferon alpha-2b injection therapy on penile hemodynamics in men with Peyronie's disease.

Muammer Kendirci1, Mustafa F Usta, Richard V Matern, Sepehr Nowfar, Suresh C Sikka, Wayne J G Hellstrom.   

Abstract

INTRODUCTION: Penile duplex Doppler ultrasound (PDDU) is currently the preferred method for the functional evaluation of penile hemodynamics. PDDU may be used to monitor objectively changes in penile vascular parameters in men who undergo treatment for Peyronie's disease (PD), including intralesional interferon alpha-2b (IFN alpha-2b). AIM: To investigate the impact of intralesional IFN alpha-2b therapy for PD on penile hemodynamics by using PDDU and to assess the objective role of PDDU in monitoring treatment outcomes.
MATERIALS AND METHODS: Thirty-nine patients (20 in the placebo and 19 in the IFN alpha-2b treatment arm) were enrolled in this prospective, placebo-controlled, parallel study. Patients received either 10 mL saline or 5 x 10(6) units of IFN alpha-2b intralesional injections every other week for a total of six injections. Patients in each group were evaluated at baseline and after completion of treatment regarding changes in penile hemodynamic parameters, penile curvature, plaque size and density, pain on erection, and erectile function. Specific published criteria were used for PDDU measurements. Outcomes were statistically compared between each group by using Mann-Whitney U and chi-square tests.
RESULTS: The mean age of the patients and the duration of PD were similar in both groups. The improvement in penile blood flow was significantly greater in IFN alpha-2b-treated patients than those in the placebo group. The number with the nonvascular classification increased significantly in the IFN alpha-2b arm from 31.5% to 57.8%. Additionally, improvements in penile curvature, plaque size and density, and pain on erection were better in the IFN alpha-2b group compared with the control. No significant improvement was observed in the erectile function domain in either group.
CONCLUSION: This study reveals that intralesional IFN alpha-2b injections have a significant benefit on penile hemodynamic parameters. Moreover, intralesional IFN alpha-2b is an effective, minimally invasive treatment for PD, and PDDU is a useful adjunct to monitor objectively changes in penile vascular parameters. interferon alpha-2b injection therapy on penile hemodynamics in men with Peyronie's disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16422829     DOI: 10.1111/j.1743-6109.2005.00110.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  11 in total

1.  PEYRONIE'S DISEASE: A REVIEW OF ETIOLOGY, DIAGNOSIS, AND MANAGEMENT.

Authors:  Aylin N Bilgutay; Alexander W Pastuszak
Journal:  Curr Sex Health Rep       Date:  2015-06-01

Review 2.  Nonsurgical treatment options in Peyronie's Disease: 2016 update.

Authors:  Raidh A Talib; Mohammed Abdulkareem Ibrahim; Önder Cangüven
Journal:  Turk J Urol       Date:  2016-12

3.  Peyronie's Disease: AUA Guideline.

Authors:  Ajay Nehra; Ralph Alterowitz; Daniel J Culkin; Martha M Faraday; Lawrence S Hakim; Joel J Heidelbaugh; Mohit Khera; Erin Kirkby; Kevin T McVary; Martin M Miner; Christian J Nelson; Hossein Sadeghi-Nejad; Allen D Seftel; Alan W Shindel; Arthur L Burnett
Journal:  J Urol       Date:  2015-06-09       Impact factor: 7.450

Review 4.  Pharmacological Management of Peyronie's Disease.

Authors:  Landon W Trost; Serap Gur; Wayne J G Hellstrom
Journal:  Drugs       Date:  2007       Impact factor: 9.546

5.  The direction and severity of penile curvature does not have an impact on concomitant vasculogenic erectile dysfunction in patients with Peyronie's disease.

Authors:  E C Serefoglu; L Trost; S C Sikka; W J G Hellstrom
Journal:  Int J Impot Res       Date:  2014-07-17       Impact factor: 2.896

Review 6.  All about Peyronie's disease.

Authors:  Ahmed A Hussein; Amjad Alwaal; Tom F Lue
Journal:  Asian J Urol       Date:  2015-04-16

Review 7.  Injectable therapy for Peyronie's disease.

Authors:  Weiliang Chong; Ronny Ban Wei Tan
Journal:  Transl Androl Urol       Date:  2016-06

Review 8.  Nonsurgical Interventions for Peyronie's Disease: Update as of 2016.

Authors:  Gregory A Joice; Arthur L Burnett
Journal:  World J Mens Health       Date:  2016-08-23       Impact factor: 5.400

Review 9.  Peyronie's disease: What's around the bend?

Authors:  Aylin N Bilgutay; Alexander W Pastuszak
Journal:  Indian J Urol       Date:  2016 Jan-Mar

Review 10.  Medical Management of Peyronie's Disease: Review of the Clinical Evidence.

Authors:  Patrick Teloken; Darren Katz
Journal:  Med Sci (Basel)       Date:  2019-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.